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Abstract 
 
Objective: To identify the predisposing factors for pseudoaneurysm formation after 
aortic valve replacement without previous endocarditis. 
Methods: Echocardiography was used to identify patients. Parameters with influence 
on the occurrence of pseudoaneurysms were analyzed and the odds ratio for the 
influence of the type of valve was estimated. The Chi-squared goodness-of-fit test 
was used to analyze if either location or underlying etiology are associated with an 
accumulated occurrence of a pseudoaneurysm. Fisher’s Exact test was used to 
assess a possible relation between occurrence of a pseudoaneurysm after composite 
graft implantation and etiology or location. 
Results: Patients treated with a composite graft had a 27-fold increased risk to 
develop a pseudoaneurysm (MH=27, 95%-CI: 1.61-454.19) in comparison to aortic 
valve replacement only. There was a significant difference for the probability of 
different etiologies to occur (p=0.032), with Stanford type A aortic dissection and 
aortic regurgitation being the most often occurring pathologies. A significant 
association between the use of a composite graft and both the underlying etiology 
(p=0.002) and the location of the pseudoaneurysm (p=0.04) was found. Furthermore, 
patients with a composite graft had a larger diameter of the aortic root as compared 
to patients with aortic valve replacement only (p=0.03). Neither the diameter of the 
annulus of the aortic valve (p=0.41; 95%-CI: 0.89-1.32) nor the diameter of the 
ascending aorta (p=0.54; 95%-CI: 0.27-1.97) had any influence on pseudoaneurysm 
formation. 
Conclusions: The underlying disorder, determining the surgical procedure, influences 
the risk for the development of a pseudoaneurysm in patients without previous 
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endocarditis. Location of most pseudoaneurysms at the level of the aortic root may 
be a consequence of its larger diameter. 
 
 
Keywords: pseudoaneurysm, aorta, aortic valve replacement, composite graft, 
homograft 
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Introduction 
 
Pseudoaneurysm (false aneurysm, PA) formation is a potential late complication after 
aortic valve replacement (AVR) with potentially fatal consequences including high 
rates of rupture, recurrence and sepsis.
 1 Predisposing factors for PA formation are 
dissection of the native aorta, infection, connective tissue disorders, preoperative 
chronic hypertension and aortic calcification.
 2 Echocardiography, CT and MRI are 
the non-invasive investigations of choice to diagnose PA.
 3 Although PA formation is 
a well-known complication, no data exist about predisposing factors leading to non-
infective PA development after AVR. Hence, the aim of the present study was to 
determine these factors in our collective of patients after AVR. 
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Methods 
 
Definition of pseudoaneurysm: PA was defined as a rupture of the aortic wall or 
rupture of the mitral-aortic intravalvular fibrosa, with the free wall of the 
pseudoaneurysm being made of fibrous tissue and not the aortic wall, per se. The 
communication between the perfused echo-free space within the native aortic wall 
due to partial dehiscence at the suture line and the left ventricular outflow tract was 
visualized as a systolic-diastolic color Doppler signal in transthoracic 
echocardiography (Figure 1A and 1B).
 1 Typically, the onset of this signal within the 
echo-free space occurred before the onset of the systolic color Doppler signal within 
the aortic vessel wall. 
 
Patient population: We retrospectively evaluated all echocardiographic reports in 
adults (>16 years old) performed in our echocardiography laboratory during a 15- 
year-period (1992-2007) in order to identify patients with PA formation after AVR. 
Echocardiograms were carefully reviewed to confirm the diagnosis of PA before 
inclusion of the patients into the study. Criteria for the inclusion into the study were a 
preoperative echocardiography performed in our laboratory, implantation of a 
biological or mechanical aortic valve (AV) prosthesis and no evidence for 
endocarditis prior to or after AVR. In a case-control design, all patients with PA after 
AVR were matched with controls with respect to age, gender and time of operation. 
To this end, a specifically designed computer program had been used. The patients’ 
history, the pre- and postoperative clinical data and reports from the operation were 
obtained from the medical and surgical records in all cases and controls. The 
presence of a PA was compared with the type and size of the prosthesis implanted, 
the diameter of the ascending aorta, of the aortic root and of the aortic annulus. 
 
Page 5 of 23  
Pseudoaneurysm after aortic valve replacement 
Color-coded Doppler echocardiography: Doppler echocardiography was performed 
according to standard techniques using a real-time phased array sector scanner with 
integrated color Doppler facilities (3.5 MHz). Preoperative echocardiography included 
the determination of the aortic valve function, the measurement of the annulus size of 
the AV, the diameter of the ascending aorta and of the aortic root. Measurements of 
the annulus size were performed in the two-dimensional long axis view of the left 
ventricle and of the left ventricular outflow tract. Measurements of the ascending 
aorta and of the aortic root were performed in the two-dimensional long axis view of 
the aortic root and of the ascending aorta, respectively, using M-Mode 
echocardiography. The postoperative development of a PA was defined as a 
perfused, echo-free space communicating with the left ventricular outflow tract as 
described above. 
 
Operative Technique for AVR: The heart was exposed through a median sternotomy. 
After heparinisation the ascending aorta and right atrium were cannulated, and 
cardiopulmonary bypass (CPB) was initiated. The patients were cooled to 30°C. The 
aorta was crossclamped, and blood cardioplegia was infused antegradely and 
retrogradely. The aortic valve was exposed through an oblique/transverse aortotomy. 
The native aortic valve was excised and the annulus thoroughly decalcified. The 
selection of the correct size of the aortic valve prosthesis was performed on the basis 
of the preoperatively measured annulus size and by sizing of the annulus using 
appropriate valve sizers. Valve implantation was typically in a supra-annular position, 
using a non-everting suture technique with 2.0 Ticron suture (Ethicon, 
Johnson&Johnson Inc, New Jersey, USA). Rewarming was started, aortotomy was 
closed and the aorta declamped. The patients were weaned from CPB, and the 
cannulae were removed. Protamine was administered, and the operation was 
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terminated in a standardized fashion. The operative technique described here did not 
substantially change over the observation period of our study. 
 
Statistical analyses: The analyses were done using the statistical software package 
R version 2.7.2. for Mac OS X. A case-control study design with 1:1 matching for age 
and gender was selected. The influence of the type of valve on the development of 
PA was examined after grouping the implanted aortic valves into the following 
categories: Mechanical prostheses, biological prostheses, homografts, and 
composite grafts. The Mantel-Haenszel estimator was used to estimate the odds 
ratio for the influence of the type of valve. The diameters of the aortic root and of the 
ascending aorta were compared between AVR and composite grafts using the 
nonparametric Mann-Whitney-test. Furthermore, differences of the annulus size, as 
determined preoperatively by echocardiography, and of the size of the implanted AV 
prosthesis were compared between patients who developed PA and controls using 
conditional logistic regression analysis. To analyze differences between the different 
locations and etiologies leading to pseudoaneurysms, the Chi Squared Goodness-of-
fit test for equal probabilities was used. To assess if there is a relation between the 
occurrence of PA after composite graft implantation and etiology or location of PA, 
Fisher’s Exact Test was used. A p-value of < 0.05 was regarded as statistically 
significant, and 95%-confidence intervals were calculated. 
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Results 
 
Patient population 
During a 15-year-period from 1992 until 2007, 24 patients fulfilling the inclusion 
criteria were identified and matched to controls. PA was detected in 13% (n=3) of the 
patients after implantation of a homograft, in 29% (n=7) of the patients after 
implantation of a mechanical or biological valve prosthesis and in 54% (n=14) of the 
patients after implantation of a composite graft. Mean age at diagnosis was 52 years 
(range: 20-87 years). Eighteen patients were male, six female (Table 1). 38% of the 
patients (n=9) had undergone previous aortic valve surgery. There was no significant 
difference in the concomitant occurrence of arterial hypertension between cases 
(38%, n=9) and controls (25%, n=6) (p=0.16; ns). There were two patients in the 
case group with Marfan syndrome, whereas in the control group one patient with 
Marfan syndrome and one patient with Shone's complex could be identified. The 
mean time from operation to first documentation of PA was 705±1482 days (range 1-
6289 days, median 68 days). 
 
Influence of a mismatch between AV annulus diameter and aortic prosthesis size 
To analyze the influence of the relation between AV annulus diameter preoperatively 
assessed by echocardiography and the size of the implanted aortic valve, the 
differences between the AV annulus diameter and the aortic valve size were 
calculated. The median difference was 1 mm (range: -5 mm to +8 mm) in the PA 
group and 0 mm (range: -6 mm to +5 mm) in the control group. In five patients with 
pseudoaneurysm and in four patients of the control group, there was no difference 
between the AV annulus and the implanted aortic valve size at all. Overall, no 
significant difference was detected between AV annulus diameter and the size of the 
implanted aortic valve (p=0.74; 95%-CI: 0.21-2.98 for odds ratio of 0.8). In 24% of the 
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patients in the case group (n=6) and in 67% of the patients in the control group 
(n=16) calcifications of the aortic annulus were detected. 
 
Influence of the type of valve 
The type of prosthesis (i.e. mechanical or biological prosthesis) had no significant 
influence on the development of PA (p=0.74; 95%-CI: 0.34-4.65). We also tested the 
influence of the type of valve implanted (AVR (n=7) or composite graft (n=14)). The 
Mantel-Haenszel estimator revealed that patients treated with a composite graft had 
a steeply (27-fold) increased risk to develop PA after AVR (MH=27; 95% CI: 1.61-
454.19). Due to the low number of patients that received a homograft (n=3), these 
patients had been excluded from the analysis. 
 
Influence of preexisting pathologies 
The indication for valve replacement was based on the following etiologies: aortic 
valve insufficiency in 8 patients, aortic dissection (Stanford classification A) in 7 
patients, combined stenotic and insufficient tricuspid aortic valve in 4 patients and a 
combined stenotic and insufficient bicuspid aortic valve in 2 patients. Rupture of the 
sinus of valsalva and aneurysm of the ascending aorta was documented in one 
patient each. The Chi Squared Goodness-of-fit test revealed a significant difference 
between the probabilities of different etiologies (p=0.032). 
 
Influence of the location of the pseudoaneurysms 
In 9 patients the PA was located at the non-coronary aortic sinus, in 6 patients the 
PA was located at the right coronary aortic sinus and in 3 patients at the left coronary 
aortic sinus. In 2 patients the PA was located at the ascending aorta and in 4 
patients, a combination of the locations was detected. However, we did not find any 
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difference between the probability of the occurrence of a PA at these locations 
(p=0.170). 
 
Influence of location and etiology on the occurrence of pseudoaneuryms after 
composite graft implantation 
A composite graft was implanted in 14 patients. In 7 patients the composite graft was 
implanted after aortic dissection (Stanford classification A), in 4 patients a composite 
graft was implanted for aortic insufficiency. Rupture of the sinus of Valsalva and 
aneurysm of the ascending aorta was the underlying pathology and the indication for 
replacement with a composite graft in one patient each. We detected a significant 
association between the use of a composite graft and the underlying etiology 
(p=0.002). Furthermore, there was also a significant association between the location 
of PA and the implantation of a composite graft (p=0.04). PA located at the non-
coronary and at the right coronary aortic sinus occurred more often than at other 
sites. 
 
Influence of the diameter of the AV annulus, the aortic root and the ascending aorta  
Mean diameter of the aortic root, obtained before surgery, was 56±16 mm (range 26-
99 mm) in patients with composite grafts, which was significantly larger (p=0.03) than 
the corresponding mean diameter in patients with AVR (38±6 mm; range 31-39 mm) 
(Figure 2A). Mean diameter of the ascending aorta was 39±8 mm (range 29-61 mm), 
and did not statistically significant differ from that of patients with AVR (36±5 mm; 
range 28-42 mm) (p=0.852; ns) (Figure 2B). 
We then tested the influence of the diameter of the annulus of the ascending aorta 
and of the aortic root on the development of PA. However, neither the diameter of the 
AV annulus (p=0.41; 95%-CI: 0.89-1.32) nor the diameter of the ascending aorta 
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(p=0.54; 95%-CI: 0.27-1.97) had any influence on PA formation in the logistic 
regression analysis. However, there was a trend towards an influence of the diameter 
of the aortic root on PA formation (p=0.051; 95%-CI: 0.99-5.63). With a p-value only 
slightly above the significance level, there is certainly a tendency towards the 
development of PA in the presence of larger diameters of the aortic root. 
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Discussion 
 
We found in this case-control study a close association between implantation of a 
composite graft and the development of a PA in patients without previous 
endocarditis. Furthermore, among all patients with PA, those with a composite graft 
had a significantly larger aortic root than those who received an AVR only. When 
eventually seeking to determine possible variables which might have an influence on 
the occurrence of a PA in this setting, and which may therefore shed light on the 
underlying mechanisms, we again found a higher diameter of the aortic root, but not 
of the ascending aorta nor of the aortic valve annulus, as a possible determinant. 
However, although there was a strong tendency for a PA to develop in the presence 
of larger diameters of the aortic root, this trend failed to reach statistic significance. 
Most interestingly, we also found a significant difference for the probability of the 
different etiologies to occur, with Stanford type A aortic dissection and aortic 
regurgitation (irrespective of its underlying reason) being the most often occurring 
pathologies. Furthermore, a significant association between the implantation of a 
composite graft and both the underlying etiology and the location of the PA could 
also be detected. PA occurred most often at the non-coronary and at the right 
coronary aortic sinus. This means that the underlying disorder determines the 
eventually performed surgical procedure, which, in turn, influences the risk that a PA 
will develop. Obviously, one has to admit that insertion of a composite graft carries 
an inherent risk of PA formation, as there are more suture lines (annulus, coronary 
artery anastomoses, or distally in the aortic arch) as compared with AVR only. 
However, analysis of the location of PA revealed that all but two PAs, which were 
more distal in the ascending aorta, were at the level of the aortic root. Therefore, also 
taking into account that an extremely experienced echocardiographer (R.J.) looked 
thoroughly for PA at all sites at which they may have occurred, we hypothesize that 
Page 12 of 23  
Pseudoaneurysm after aortic valve replacement 
the fact of an increased diameter of the aortic root in these patients may have a 
distinct pathophysiological meaning, possibly via an increased likelihood of intimal 
rupture. 
Several morphological changes of the aortic annulus can be found after AVR. Hence, 
most of these findings are incidental and innocuous in nature. PA formation occurs 
rather rarely after AVR, but it is important to recognize this complication after aortic 
repair to improve late outcome.
 4 Although the clinical symptoms associated with PA 
formation may be non-specific or even completely absent, some patients may be 
severely limited by dyspnoea and fatigue, probably secondary to reduced cardiac 
output and/or left ventricular volume overload.
 5 Furthermore, as there is the 
imminent possibility of aortic rupture, early diagnosis of aortic pseudoaneurysm is 
essential.
 5 
The preoperative assessment of the diameter of the aortic valve annulus allows 
improved matching of patients and valve prosthesis and, thereby, yields improved 
long-term results after AVR.
 6 Hence, preoperative transthoracic and 
transoesophageal echocardiography accurately predict the size of aortic valve 
prosthesis and therefore may reduce CPB time.
 7 However, our data indicate that a 
difference between the annulus size initially measured in preoperative 
echocardiography and the size of the aortic valve eventually implanted had no 
influence on PA formation. Somewhat surprisingly, our patients with PA formation 
had aortic annuli that were less calcified than those of control patients. Therefore, our 
data suggest that calcifications of the aortic annulus have no effect on PA formation. 
The development of PA is a complication following composite graft replacement,
 5, 8 
and homograft replacement
 1 of the aortic valve and the ascending aorta. 
Kouchoukos found nine patients with PA in a study of 127 patients with composite 
grafts,
 8 Barbetseas described eight patients with PA of the ascending aorta in 35 
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patients with composite aortic grafts,
 5 and Oechslin found a PA in 22 out of 30 
patients after homograft implantation.
 1 
In the study showing that patients after homograft implantation have a greater risk to 
develop PA,
 1 patients with previous endocarditis were included, while these patients 
were excluded in our study. Indeed, PAs were often localized at the site of an 
abscess or a paravalvular leak after prosthetic valve endocarditis. In contrast to this 
study, we specifically aimed at identifying underlying factors for the development of 
PA in the absence of endocarditis. 
Barbetseas and colleagues previously found eight patients with PA of the ascending 
aorta after composite graft replacement in a series of 35 patients with composite 
aortic grafts.
 5 Unlike our patients, most of these patients (seven out of eight) had a 
major risk factor (four with Marfan, two with hypertension, one with Marfan and 
hypertension). They found an increased diameter (mean 90±30 mm, range 60-140 
mm) of the ascending aorta in patients who developed PA as compared with those 
without PA (mean 42±6 mm, range 32-50 mm). In contrast, in our study, the diameter 
of the ascending aorta was much smaller (mean 38±8 mm, range 25-61 mm) and did 
not significantly differ from the diameter in the control group (mean 38±5 mm, range 
27-48 mm). However, we found in our patients with PA the aortic root enlarged as 
compared with controls (mean 48±19 mm, range 26-99 mm vs. mean 37±6 mm, 
range 28-54 mm), and there was a striking trend towards an increased risk for the 
development of PA in patients with an enlarged aortic root. This also holds true when 
only our two patients with PA localized to the ascending aorta are taken into account 
(aortic root: 51 and 74 mm; ascending aorta: 47 and 30 mm). 
While postoperative morphological changes of the aortic annulus can be found after 
AVR, most of them are innocuous. The development of a pseudoaneurysm is, 
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however, possible and is certainly an underrecognised complication, which may lead 
to serious consequences.  
Most importantly, our data also suggest that baseline pathology predisposes to the 
development of postoperative PA. This may imply that the underlying disease (i.e. 
Stanford type A dissection and aortic regurgitation, irrespective of its etiology), 
necessitating composite grafting, and not only just the type of operation (i.e. 
implantation of a composite graft) leads to an increased incidence of PA. 
Although probably underrecognized, especially noninfectious PAs seem to be a 
rather rare complication. This is underlined by the fact that nearly 3700 aortic valve 
operations were performed at our institution during the observation period. The 
incidence of noninfectious PA was below 1%. However, it increased to around 4% in 
composite grafts and homografts, respectively. From our experience, unlike the 
management of PA in the setting of a postoperative infection, watchful waiting with 
close echocardiographic controls is the appropriate procedure for noninfectious PA. 
Normally, transthoracic echocardiography should be sufficient, at least in patients 
with good image quality. In the series presented here, no patient had to undergo re-
operation for PA during a follow-up period of several years. As most PAs only 
develop a long time after operation (see results), postoperative follow-up of all 
patients, irrespective of the type of operation, may initially be the same. 
Taken together, in the setting of AVR without previous endocarditis, patients with a 
composite graft replacement have an increased risk to develop PA, while patients 
having undergone AVR only have not. Patients with composite grafts developing PA 
are characterized by an increased aortic root. As patients with an increased diameter 
of the aortic root tended to have an increased risk to develop PA in general, one may 
assume that the type of valve together with the diameter of the aortic root are among 
the key parameters to be taken into account in the preoperative risk assessment of 
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patients undergoing AVR with respect to the possibility of the occurrence of a PA. 
The degree of calcifications of the aortic root may play an additional role. However, 
we suggest that the underlying pathology that necessitated aortic valve replacement 
or composite grafting may well be another important key parameter. Although our 
data suggest a close association between the etiology that led to the implantation of 
a composite graft and the development of PA after graft implantation, this relationship 
does not necessarily imply causality. Location of most PAs at the level of the aortic 
root underlines the importance of our finding of an increased risk of PA after 
composite grafting in association with an increased diameter of the aortic root. 
 
Limitations 
We are aware of the fact that the patient number of our study was too small to draw 
any definite conclusions. However, PA is indeed a rather rare complication, and all 
cases of PA without endocarditis after AVR in our tertiary care institution over a 15-
year-period had been taken into account. 
We found a remarkable probability to develop PA in patients with composite grafts. 
Given a relatively large CI, however, the chance for a PA might only be as twice as 
high as in patients with AVR only. 
The significant Fisher’s Exact test strongly suggests a close association between the 
implantation of a composite graft and the location of PA. Using logistic regression, 
one could exactly quantify this association. However, such an analysis would be 
worthless in our setting as PA only occurred after the surgical procedure. 
The controls for our case-control pairs had been chosen according to age, gender 
and time of operation using a computer program designed for this purpose. 
Therefore, it cannot be completely ruled out that the number of patients with 
composite grafts within our controls might have been low by chance only. 
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At last, it was beyond the scope of this study to analyze other factors such as a sub-
clinical endocarditis, or the surgeon himself, i.e. his experience, and, at least 
theoretically depending on this, the pump time or any trauma involved. All operations 
done at our institution were performed by very experienced heart surgeons. 
However, we feel unable to statistically analyze these factors in a valid way in this 
retrospective study. 
 
Conclusions 
Noninfectious PAs are a rather rare complication in patients after AVR with an 
incidence in our cohort of <1%. However, in patients with composite grafts and 
homografts, this value increases to 4%. Unlike the management of infective PAs in a 
postoperative setting, our data suggest that noninfectious PA is a relatively benign 
condition, making watchful waiting and repeated echocardiography the procedure of 
choice in these patients. This recommendation is based on our series, where no 
patient had to undergo reoperation for PA during the follow-up period of several 
years. However, PAs were detected after a median of 68 days after AVR. This 
means that in general PAs develop relatively early in the postoperative period. Based 
on our data, we therefore suggest the first non-invasive follow-up using TTE three 
months after AVR, in particular in those patients in whom a composite graft had been 
inserted. 
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Figure legends 
Figure 1: Echocardiographic visualization of a pseudoaneurysm in end systole 
without (A) and with (B) color-mode. 
Figure 2: Box plots showing the distribution of diameters of the aortic root (A) and of 
the ascending aorta (B) in patients with PA previously undergoing composite graft 
implantation or aortic valve replacement only. 
 
Pseudoaneurysm after aortic valve replacement 
 
Table 1: Clinical and echocardiographic characteristics of all patients who developed a pseudoaneurysm without a history of 
endocarditis 
 
Pa
t 
Gende
r 
Age Cusps   AV-
Annulu
s 
  
Aortic root 
  Aorta 
ascendens 
Type of 
Prosthesis
  AV- 
Prosthesis 
Localization Etiology Time to 
PA 
(days)
1 M 60 2 24 39 38 CM 23 NC bicusp. 54 
2 M 60 3 24 N/A N/A SJM 23 NC tricusp. 1 
3 M 41 3 24 59 61 CM (Comp.) 23 LC A-Dissection 63 
4 M 57 3 27 74 30 CM (Comp.) 25 AA A-Dissection 9 
5 F 57 0 21 31 40 Shelhigh (Comp.) 21 RC Aortic insufficiency 73 
6 M 39 0 31 50 37 Homograft 28 LC Aortic insufficiency 216 
7 M 20 0 23 26 40 SJM (Comp.) 25 NC/LC unknown 6289 
8 M 47 3 30 59 29 Shelhigh (Comp.) 27 RC A-Dissection 21 
9 F 66 0 29 31 29 CE (Comp.) 29 NC Sinusruptur 2611 
10 F 67 0 25 51 47 CM (Comp.) 25 AA Aneurysm ascend. 163 
11 M 48 0 29 N/A N/A SJM (Comp.) 31 NC Aortic insufficiency 1 
12 F 65 3 21 35 38 CE 21 NC tricusp. 57 
13 M 21 3 23 35 N/A Homograft 20 NC/RC Aortic insufficiency 182 
14 M 82 3 21 39 37 ELS 23 NC tricusp. 8 
15 M 35 2 39 99 N/A CM (Comp.) 31 RC A-Dissection 104 
16 M 62 0 21 31 35 Homograft 19 NC Aortic insufficiency 22 
17 F 46 3 24 59 42 SJM (Comp.) 25 RC/LC Aortic insufficiency 6 
18 M 64 3 25 69 25 Composite 25 RC A-Dissection 56 
19 M 87 3 22 31 28 CE 21 RC/NC tricusp. 192 
20 M 50 0 22 36 44 Shelhigh (Comp.) 21 NC Aortic insufficiency 15 
21 M 30 2 27 38 42 CM 25 LC bicusp. 1310 
22 F 58 3 26 63 43 Shelhigh (Comp.) 25 NC A-Dissection 581 
23 M 47 0 29 31 31 CM 25 RC Aortic insufficiency 3425 
24 M 62 3 24 67 N/A SJM (Comp.) 29 RC A-Dissection 1440 
 
Pat = Patient. 
Cusps = Number of Cusps of AV, 0 indicates replaced AV during previous AV-operation. 
  = Diameter in Millimetre. 
Type of prosthesis: CE = Carpendier Edwards. CM = Carbomedics. ELS = Edwards Life Science. SJM = St. Jude Medical. (Comp.) = Composite graft. 
N/A = not measured at time of echocardiography. 
Localization: NC = non-coronary aortic sinus. LC = left coronary aortic sinus. RC = right coronary aortic sinus. 
Etiology: Bicusp. = combined stenotic and insufficient bicuspid aortic valve. Tricusp. = combined stenotic and insufficient tricuspid aortic valve. A-Dissection = 
aortic dissection (Stanford classification A). Sinusruptur = Rupture of the sinus of valsalva. Aortic insufficiency = Aortic valve insufficiency. Aneurysm ascend. = 
Aneurysm of the ascending aorta
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Figure 1: 
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Figure 2: 
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